What Healthcare Areas Does Johnson & Johnson Focus On?

Updated

Johnson & Johnson concentrates its work in two business segments, each with four named healthcare areas. Innovative Medicine covers Oncology, Immunology, Neuroscience and Cardiopulmonary. MedTech covers Cardiovascular, Orthopaedics, Surgery and Vision. According to the company's own description, both segments pursue the same goal: addressing complex diseases with science-based, more precise and less invasive treatments.

Innovative Medicine: Four Therapeutic Areas

Johnson & Johnson Innovative Medicine describes its work as "leading where medicine is going," with patients informing and inspiring its science-based innovations. The four listed healthcare areas are:

Area What the company says it covers
Oncology Cancer treatment, including cell therapy work such as CAR-T for multiple myeloma
Immunology Immune-mediated disease, including the targeted oral peptide icotrokinra (ICOTYDE®) for moderate to severe plaque psoriasis
Neuroscience Conditions of the nervous system
Cardiopulmonary Heart and lung disease

The company frames this segment around "rigorous science and compassion," aiming to address "the most complex diseases of our time."

Oncology in Practice: CAR-T for Multiple Myeloma

One concrete example of how the Oncology area operates is Johnson & Johnson's CAR-T cell therapy for multiple myeloma. The company explains that this involves transforming a patient's own cells into a targeted treatment — a complex, personalized supply chain rather than an off-the-shelf medicine. Jessica Torfs, director of Global CAR-T Supply Chain, describes what it takes to deliver this therapy. For readers trying to understand what "personalized" means in practice, this is the clearest illustration on the site.

Immunology in Practice: Targeted Oral Peptides

The company's October 2026 announcement notes that ICOTYDE® (icotrokinra) was named to Time's Best Inventions of 2026 list. It is described as a first-of-its-kind targeted oral peptide therapy for moderate to severe plaque psoriasis. A related article explains the underlying challenge: delivering peptide therapies orally while hitting their target more precisely — a problem the company says has long frustrated drug developers.

MedTech: Four Device and Technology Areas

Johnson & Johnson MedTech describes itself as innovating "at the intersection of biology and technology," with a focus on treating with pinpoint precision in hard-to-reach parts of the body, restoring anatomy and reimagining healing. Its four healthcare areas are:

Area Focus as described
Cardiovascular Heart and vascular intervention
Orthopaedics Restoring anatomy and joint function
Surgery Surgical systems and precision treatment
Vision Eye care and vision correction

The segment's stated portfolio is "smarter, less invasive, more personalized treatments." One example referenced on the site is the OTTAVA™ Robotic Surgical System, with a behind-the-scenes article on its development.

How the Two Segments Fit Together

The common thread across all eight areas is a stated preference for precision over broad intervention: pinpoint treatment in hard-to-reach anatomy, less invasive procedures, and therapies tailored to individual patients. The site's framing — "a world where complex diseases are prevented and cured, treatments are smarter and less invasive—and solutions are personal" — applies to both medicines and devices.

If you want to go deeper, the most substantive examples on the site are the CAR-T manufacturing explainer (Oncology) and the targeted oral peptide science article (Immunology). For corporate results context, the site also publishes an infographic breakdown of quarterly earnings covering both Innovative Medicine and MedTech performance.